Kerala Ayurveda Limited

BSE: 530163
Kerala Ayurveda Limited - healthcare in Aluva, Kerala, India. FY 2026 financials & compliance.
CIN L24233KL1992PLC006592 Incorporated 06 July 1992 ROC Ernakulam HQ Aluva, Kerala, India
Active Listed - BSE: 530163 Public Limited Company healthcare MSME · Medium
Market Cap
₹208 Cr
KERALAYUR · BSE
Share Price
₹149.85
-1.48% today
Revenue
₹131 Cr
FY 2025-26 · +4.4% YoY
EBITDA
−₹17.75 Cr
Margin -13.5%
Net Profit
−₹16.56 Cr
FY 2025-26 · -18.7% YoY
Authorised capital
₹15 Cr
Registered with MCA
Paid-up capital
₹13 Cr
Issued & subscribed
Open charges
₹18.4 Cr
Satisfied ₹74.75 Cr

About Kerala Ayurveda Limited

Data last updated:

Kerala Ayurveda Limited is a public limited company based in Aluva, Kerala, India, a subsidiary of Katra Holdings Limited, Mauritius. It operates in the ayurvedic products and services segment of the healthcare sector. It was incorporated on 06 July 1992 and has been in existence for over 34 years.

The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN L24233KL1992PLC006592. Its GSTIN is 32AABCK4228Q2ZC (Kerala). The company holds 15 GST registrations, of which 11 are active. It is a listed company as per MCA records. Its shares are listed on BSE: 530163.

The company has an authorised share capital of ₹15 Cr and a paid-up capital of ₹13 Cr. It was formerly known as Pensum Ayurveda Pharmaceuticals Limited and Kerala Ayurveda Pharmacy Limited. It is led by directors including Kunjupanicker Anilkumar (Whole-Time Director) and Shilpa Kiran Gududur.

Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Aluva, Kerala.

As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹131.15 Cr, a growth of 4.4% compared to the previous year. For the same year it recorded a net loss of ₹16.56 Cr (net margin -12.6%) and EBITDA of -₹17.75 Cr (EBITDA margin -13.5%).

The company has about 592 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.

The company is associated with 2 brands: The Health Village and Kerala Ayurveda. As per MCA filings, the company has open charges of ₹18.4 Cr and satisfied charges of ₹74.75 Cr on record. Court records list 71 cases involving the company, including 41 filed by the company and 30 filed against it; 16 cases are pending. The company has 39 deals on record (35 market trades, 4 funding rounds), with disclosed funding of ₹38.89 Cr; the latest was in August 2026. Its 4 peer companies in the Healthcare industry (Ayurvedic Products and Services), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 1 larger and 3 smaller; the largest is Star Hi Herbs Private Limited with revenue of ₹136.51 Cr. The company has 8 MSME Form 1 returns on record between 2020 and 2024, listing 168 overdue payments to 24 micro and small suppliers.

Kerala Ayurveda Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-KL-02-0010246). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website keralaayurveda.biz.

Company details

CIN L24233KL1992PLC006592
Registration Number 006592
Incorporation Date 06 July 1992
ROC Ernakulam
Listing Status Listed - Listed on BSE (530163)
Company Status Active
Parent Company Katra Holdings Limited, Mauritius
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-KL-02-0010246

Name history

Kerala Ayurveda has undergone 2 name changes throughout its history. The company was previously known as Pensum Ayurveda Pharmaceuticals Limited, and Kerala Ayurveda Pharmacy Limited. The current legal name is Kerala Ayurveda Limited.

Company NameStatus
Kerala Ayurveda LimitedCurrent
Pensum Ayurveda Pharmaceuticals LimitedPrevious
Kerala Ayurveda Pharmacy LimitedPrevious
Key People
Kunjupanicker Anilkumar Whole-Time Director Shilpa Kiran Gududur Director Rajesh Sharma Director

Recognitions & Rankings of Kerala Ayurveda

MSME (Udyam registered) Ministry of MSME
Category
Medium (2023-24)
Udyam number
UDYAM-KL-02-0010246

Contact details

Kerala Ayurveda Limited's registered office is in Aluva, Kerala. Its website is keralaayurveda.biz. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    keralaayurveda.biz
  • Social Media
  • Registered Address
    Xv/ 551, Nedumbassery, Aluva, Kerala, India – 683585
  • Industry
    Healthcare, Ayurvedic Products & Services

To see the full contact details of Kerala Ayurveda Limited, buy the company report.

Comprehensive company report
Kerala Ayurveda Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Kerala Ayurveda operates two associated brands: The Health Village and Kerala Ayurveda. Each brand links to its own profile.

BrandDescriptionWebsite
Kerala Ayurveda
Chain of complementary and alternative therapy hospitalskeralaayurveda.biz
The Health Village
Ayurvedic treatments, holistic healing, and wellness services in Kerala.thehealthvillage.biz

Business activity

The main business activities of Kerala Ayurveda are manufacturing and hospital and medical care. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and other hospital and medical care activities. 2 activity segments are registered with the MCA.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products
QHospital and Medical CareQ6Other Hospital and Medical Care Activities

To see the full business activity and turnover split of Kerala Ayurveda Limited, buy the company report.

Financials of Kerala Ayurveda Limited

FY 2025-26 filings available

Kerala Ayurveda Limited reported revenue of ₹131.15 Cr (up 4.4% YoY) for FY 2025-26.

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹131 Cr
+4.4% YoY
EBITDA
−₹17.75 Cr
-256.4% YoY
Profit After Tax
−₹16.56 Cr
-18.7% YoY
Net Worth
-
Total Assets
-
Total Debt
-

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue13112610893.4180.3562.0776.77
Revenue growth+4.4%+16.0%+15.9%+16.3%+29.5%-19.2%-
EBITDA(17.75)(4.98)8.532.619.520.837.36
EBITDA margin-13.5%-4.0%+7.9%+2.8%+11.9%+1.3%+9.6%
Profit before tax(16.37)(12.23)0.65(0.57)2.79(6.75)4.54
Net profit(16.56)(13.95)(0.57)(2.98)1.69(4.86)3.90
Net profit margin-12.6%-11.1%-0.5%-3.2%+2.1%-7.8%+5.1%
EPS (₹)(13.53)(11.60)(0.47)(0.85)2.24(4.59)3.69
Balance sheet
Total assets-89.2310385.2382.6890.7582.81
Net worth-9.4918.655.586.113.417.93
Total debt-70.6676.0672.4469.9476.6964.16
Cash & bank-3.3922.813.202.8718.566.37
Net working capital-1.2425.974.589.5019.9214.11
Cash flow
Cash from operations-4.83(0.96)9.86(0.50)7.434.99
Cash from investing-(14.77)(0.45)(7.22)(1.91)(1.44)(4.03)
Cash from financing-(9.48)19.83(2.32)(13.27)6.200.85
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue33.1934.7432.9634.8428.6131.3231.1330.41
Revenue growth (YoY)+16.0%+10.9%+5.9%+14.6%+4.2%---
Other income0.261.911.131.709.470.730.230.64
EBITDA(3.83)(7.10)(1.51)(4.95)(4.19)(10.14)(1.19)5.53
EBITDA margin-11.5%-20.4%-4.6%-14.2%-14.6%-32.4%-3.8%+18.2%
Depreciation1.871.691.150.991.651.920.721.98
Interest2.791.102.842.580.822.480.430.72
Profit before tax(8.23)(7.98)(4.37)(6.82)2.81(13.81)(2.11)3.47
Tax(0.15)(0.59)0.23(0.46)0.781.560.59(0.17)
Net profit(8.08)(7.39)(4.60)(6.36)2.03(15.37)(2.70)3.64
EPS (₹)(6.24)(5.83)(3.81)(7.23)1.89(12.78)(2.40)3.10
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue85.4877.9573.1463.3055.8043.2053.68
Revenue growth+9.7%+6.6%+15.6%+13.4%+29.2%-19.5%-
EBITDA(23.02)(12.60)3.807.787.720.213.09
EBITDA margin-26.9%-16.2%+5.2%+12.3%+13.8%+0.5%+5.8%
Profit before tax(15.96)(13.50)(0.16)2.391.22(6.58)1.20
Net profit(14.75)(13.80)0.060.480.87(4.95)0.86
Net profit margin-17.3%-17.7%+0.1%+0.8%+1.6%-11.5%+1.6%
EPS (₹)(12.21)(11.45)0.042.740.84(4.69)0.83
Balance sheet
Total assets-86.0310282.8077.2084.6181.04
Net worth-25.1232.7714.5411.2810.0514.67
Total debt-55.5663.5763.6361.3966.0257.80
Cash & bank-0.3616.491.730.131.071.90
Net working capital-37.4130.1810.088.8916.1715.72
Cash flow
Cash from operations-2.28(5.30)9.128.75(0.91)4.71
Cash from investing-(6.48)(0.54)(5.32)0.83(2.10)(3.93)
Cash from financing-(11.93)20.59(2.27)(10.52)2.180.29
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue22.5324.5722.0721.2917.5719.3519.3518.60
Revenue growth (YoY)+28.2%+27.0%+14.1%+14.5%+14.1%---
Other income1.284.700.982.2610.004.370.130.39
Total expenses27.6235.0524.1326.3322.9930.3418.9919.15
EBITDA(5.09)(10.48)(2.06)(5.04)(5.42)(10.99)0.36(0.55)
EBITDA margin-22.6%-42.7%-9.3%-23.7%-30.8%-56.8%+1.9%-3.0%
Depreciation1.411.240.580.551.231.460.280.22
Interest2.811.971.982.540.772.810.380.33
Profit before tax(8.03)(8.99)(3.64)(5.87)2.58(10.89)(0.17)(0.71)
Tax(0.36)(1.07)(0.18)(0.47)0.510.98(0.08)(0.17)

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 13 Nov 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue33.1934.7432.9634.8428.6131.3231.1330.41
Revenue growth (YoY)+16.0%+10.9%+5.9%+14.6%+4.2%---
Other income0.261.911.131.709.470.730.230.64
EBITDA(3.83)(7.10)(1.51)(4.95)(4.19)(10.14)(1.19)5.53
EBITDA margin-11.5%-20.4%-4.6%-14.2%-14.6%-32.4%-3.8%+18.2%
Depreciation1.871.691.150.991.651.920.721.98
Interest2.791.102.842.580.822.480.430.72
Profit before tax(8.23)(7.98)(4.37)(6.82)2.81(13.81)(2.11)3.47
Tax(0.15)(0.59)0.23(0.46)0.781.560.59(0.17)
Net profit(8.08)(7.39)(4.60)(6.36)2.03(15.37)(2.70)3.64
EPS (₹)(6.24)(5.83)(3.81)(7.23)1.89(12.78)(2.40)3.10
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue13112610893.4180.3562.0776.77
Revenue growth+4.4%+16.0%+15.9%+16.3%+29.5%-19.2%-
Other income14.211.820.303.121.140.110.02
Total expenses14913199.7390.8070.8361.2469.41
Employee cost0.0054.2734.3228.1222.3122.0024.63
EBITDA(17.75)(4.98)8.532.619.520.837.36
EBITDA margin-13.5%-4.0%+7.9%+2.8%+11.9%+1.3%+9.6%
Depreciation5.494.982.141.111.201.281.14
Interest7.344.096.045.196.676.411.70
Profit before tax(16.37)(12.23)0.65(0.57)2.79(6.75)4.54
Tax(0.04)1.721.22(0.13)0.41(1.89)0.48
Net profit(16.56)(13.95)(0.57)(2.98)1.69(4.86)3.90
Net profit margin-12.6%-11.1%-0.5%-3.2%+2.1%-7.8%+5.1%
EPS (₹)(13.53)(11.60)(0.47)(0.85)2.24(4.59)3.69
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital-12.0312.0310.5610.5610.5610.56
Reserves & surplus-(2.54)6.62(4.98)(4.45)(7.15)(2.63)
Shareholders' funds (net worth)-9.4918.655.586.113.417.93
Minority interest-3.402.662.301.831.801.80
Secured loans-23.2228.5812.197.0010.6110.67
Unsecured loans-47.4447.4860.2562.9466.0853.49
Total debt-70.6676.0672.4469.9476.6964.16
Total liabilities-89.2310385.2382.6890.7582.81
Assets
Gross block-77.3866.5970.1467.2254.5653.94
Net block-46.8040.8246.4244.0332.7533.41
Capital work in progress-9.236.876.844.4614.0913.66
Investments-0.050.060.030.030.030.13
Inventories-12.9612.2712.4911.9711.0012.83
Sundry debtors-19.3017.4212.9613.3410.3310.71
Cash & bank balances-3.3922.813.202.8718.566.37
Loans & advances-5.123.715.428.963.763.06
Total current assets-40.7756.2134.0737.1443.6532.97
Total current liabilities-39.5330.2429.4927.6423.7318.86
Net working capital-1.2425.974.589.5019.9214.11
Total assets-89.2310385.2382.6890.7582.81
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash-22.814.392.8718.566.374.55
Net cash from operating activities-4.83(0.96)9.86(0.50)7.434.99
Net cash from investing activities-(14.77)(0.45)(7.22)(1.91)(1.44)(4.03)
Net cash from financing activities-(9.48)19.83(2.32)(13.27)6.200.85
Net change in cash-(19.42)18.420.32(15.69)12.191.81
Closing cash-3.3922.813.202.8718.566.37
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+4.4%+16.0%+15.9%+16.3%+29.5%-19.2%-
EBITDA growth-256.4%-158.4%+226.8%-72.6%+1047.0%-88.7%-
PBT growth-33.9%-+9998.0%-+9998.0%-+46.0%
Net income growth-18.7%-2347.4%+80.9%-276.3%+134.8%-224.6%-
Revenue CAGR (3Y)+12.0%+16.1%+20.4%+6.8%+8.9%+1.8%+15.1%
EBITDA CAGR (3Y)--+117.4%-29.2%+22.3%-53.1%+0.5%
Profitability & leverage
Net income margin-12.5%-11.1%-0.5%-0.5%+3.0%-7.8%+5.3%
Return on capital employed-0.0%0.0%0.0%+9.3%0.0%+6.6%
Return on net worth-0.0%0.0%0.0%+13.3%0.0%+17.9%
Debt / equity-5.216.1312.1815.4012.4210.80
Long-term debt / equity-1.572.997.5010.059.788.77
Interest cover-31.58-41.0694.52346.0080.17-1,424.4427.33
Efficiency & per share
Fixed asset turnover-1.741.581.361.321.141.45
Inventory turnover-9.968.747.647.005.216.29
Debtors turnover-6.847.137.106.795.908.72
EPS (₹)(13.53)(11.60)(0.47)(0.85)2.24(4.59)3.69
Dividend per share (₹)0.000.000.000.000.000.000.00
Book value per share (₹)0.007.8915.505.285.793.227.51
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue22.5324.5722.0721.2917.5719.3519.3518.60
Revenue growth (YoY)+28.2%+27.0%+14.1%+14.5%+14.1%---
Other income1.284.700.982.2610.004.370.130.39
Total expenses27.6235.0524.1326.3322.9930.3418.9919.15
EBITDA(5.09)(10.48)(2.06)(5.04)(5.42)(10.99)0.36(0.55)
EBITDA margin-22.6%-42.7%-9.3%-23.7%-30.8%-56.8%+1.9%-3.0%
Depreciation1.411.240.580.551.231.460.280.22
Interest2.811.971.982.540.772.810.380.33
Profit before tax(8.03)(8.99)(3.64)(5.87)2.58(10.89)(0.17)(0.71)
Tax(0.36)(1.07)(0.18)(0.47)0.510.98(0.08)(0.17)
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue85.4877.9573.1463.3055.8043.2053.68
Revenue growth+9.7%+6.6%+15.6%+13.4%+29.2%-19.5%-
Other income17.935.173.010.060.300.170.16
Total expenses10890.5569.3455.5248.0842.9950.59
Employee cost0.0035.5220.2315.9812.1713.0616.03
EBITDA(23.02)(12.60)3.807.787.720.213.09
EBITDA margin-26.9%-16.2%+5.2%+12.3%+13.8%+0.5%+5.8%
Depreciation3.602.151.570.640.770.820.68
Interest7.273.925.404.816.036.141.37
Profit before tax(15.96)(13.50)(0.16)2.391.22(6.58)1.20
Tax(1.21)0.30(0.22)(0.52)0.35(1.63)0.34
Net profit(14.75)(13.80)0.060.480.87(4.95)0.86
Net profit margin-17.3%-17.7%+0.1%+0.8%+1.6%-11.5%+1.6%
EPS (₹)(12.21)(11.45)0.042.740.84(4.69)0.83
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital-12.0312.0310.5610.5610.5610.56
Reserves & surplus-13.0920.743.980.72(0.51)4.11
Shareholders' funds (net worth)-25.1232.7714.5411.2810.0514.67
Secured loans-13.3618.1014.0632.6310.5910.64
Unsecured loans-42.2045.4749.5728.7655.4347.16
Total debt-55.5663.5763.6361.3966.0257.80
Total liabilities-86.0310282.8077.2084.6181.04
Assets
Gross block-48.4342.7843.6040.8638.4428.43
Net block-31.4527.8030.3227.9626.4417.10
Capital work in progress-0.900.000.002.342.3411.55
Investments-9.239.2411.3711.3711.3711.47
Inventories-10.229.899.689.389.5011.46
Sundry debtors-23.1414.8012.0710.369.779.07
Cash & bank balances-0.3616.491.730.131.071.90
Loans & advances-36.553.612.503.527.454.94
Total current assets-70.2744.7925.9823.3927.7927.37
Total current liabilities-32.8614.6115.9014.5011.6211.65
Net working capital-37.4130.1810.088.8916.1715.72
Total assets-86.0310282.8077.2084.6181.04
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash-16.491.740.201.071.900.84
Net cash from operating activities-2.28(5.30)9.128.75(0.91)4.71
Net cash from investing activities-(6.48)(0.54)(5.32)0.83(2.10)(3.93)
Net cash from financing activities-(11.93)20.59(2.27)(10.52)2.180.29
Net change in cash-(16.13)14.751.52(0.94)(0.83)1.06
Closing cash-0.3616.491.730.131.071.90
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+9.7%+6.6%+15.6%+13.4%+29.2%-19.5%-
EBITDA growth-82.7%-431.6%-51.2%+0.8%+3576.2%-93.2%-
PBT growth-18.2%-8337.5%-+95.9%+9998.0%--31.0%
Net income growth-6.9%--87.5%-44.8%+117.6%-675.6%-
Revenue CAGR (3Y)+10.5%+11.8%+19.2%+5.7%+6.3%-0.4%+10.7%
EBITDA CAGR (3Y)--+162.5%+36.0%+37.0%-66.7%-13.5%
Profitability & leverage
Net income margin-17.3%-17.7%+0.1%+4.6%+1.6%-11.5%+1.6%
Return on capital employed-0.0%+5.0%+4.9%+8.4%0.0%+2.9%
Return on net worth-0.0%+0.1%+2.0%+5.4%0.0%+3.9%
Debt / equity-2.062.694.845.975.014.05
Long-term debt / equity-0.291.233.013.593.843.27
Interest cover-27.31-26.58242.1567.3786.76-1,006.5656.85
Efficiency & per share
Fixed asset turnover-1.711.691.501.411.291.93
Inventory turnover-7.757.476.645.914.124.83
Debtors turnover-4.115.445.645.544.596.00
EPS (₹)(12.21)(11.45)0.042.740.84(4.69)0.83
Dividend per share (₹)0.000.000.000.000.000.000.00
Book value per share (₹)0.0020.8827.2413.7710.689.5113.90

To see the full year-wise statements and ratios of Kerala Ayurveda Limited, buy the company report.

Board of directors of Kerala Ayurveda Limited

Kerala Ayurveda has 8 current directors and 29 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Shilpa Kiran Gududur
Also directs: Icodex Publishing Solutions Limited
Director15 Feb 20215 Years 8 MonthsCurrent
Rajesh Sharma
Also directs: Global Agri System Private Limited, Ayurvedagram Heritage Wellness Centre Private Limited, Sra Food & Beverages Private Limited and 2 more
Director28 Jun 20224 Years 4 MonthsCurrent
Kunjupanicker Anilkumar
Also directs: Kal Ayurveda Research & Education Foundation
Whole-Time Director28 Jun 200620 Years 4 MonthsCurrent
Ramesh Vangal
Also directs: Segrow Bio-Technics (India) Private Limited, Katra Holding Private Limited, Katra Phytochem (India) Private Limited and 5 more
Director02 Sep 200620 Years 2 MonthsCurrent
Saif Khan
Also directs: Count Infinity Services Private Limited
Director30 Jun 20251 Years 4 MonthsCurrent
Utkarsh Singh
Also directs: Segrow Bio-Technics (India) Private Limited, Katra Phytochem (India) Private Limited, Arudrama Developments Private Limited and 5 more
Director19 Mar 20251 Years 7 MonthsCurrent
Showing 6 of 8 current directors. View all directors

Peer comparison

Kerala Ayurveda Limited is compared with the 4 companies closest to it by revenue in the Healthcare industry (Ayurvedic Products and Services), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Star Hi Herbs Private Limited₹136.51 Cr (FY 2025)15.0%Bangalore, Karnataka, India
Kerala Ayurveda Limitedthis company₹131.15 Cr (FY 2026)-₹16.56 Cr-12.6%4.4%592Aluva, Kerala, India
Anantshriveda Private Limited₹110.48 Cr (FY 2025)38.0%Jaipur, Rajasthan, India
Cultivator Natural Products Private Limited₹104.11 Cr (FY 2025)66.0%Jodhpur, Rajasthan, India
Maharishi Ayurveda Products Private Limited₹101.67 Cr (FY 2025)2.0%New Delhi, Delhi, India

To see the full peer comparison of Kerala Ayurveda Limited, buy the company report.

Auditor

Kerala Ayurveda Limited is audited by MAHARAJ RAJAN AND MATHEW CHARTERED ACCOUNTANTS for the financial year 2023.

Auditor firmFinancial yearFirm registration number
MAHARAJ RAJAN AND MATHEW CHARTERED ACCOUNTANTSFY 2023001932S

Shareholding

Shareholding for the quarter ended Mar 2026: promoters hold 35.60%, foreign institutional investors hold 0.20%, domestic institutional investors hold 0.00% and retail and other public shareholders hold 64.20%.

Promoters: 35.60%FII (Foreign Institutional): 0.20%Retail & Others: 64.20%
Mar 2026
QUARTER
35.60% Promoters
0.20% FII (Foreign Institutional)
64.20% Retail & Others
Promoter holding - history
Now 35.60% · Mar 2026High 37.80% · Jun 2025Low 33.10% · Sep 2025
32%33.8%35.5%37.3%39%Jun 2025Sep 2025Dec 2025Mar 2026Jun 2025: 37.80%Sep 2025: 33.10%Dec 2025: 33.10%Mar 2026: 35.60%37.80%33.10%35.60%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025
Promoters35.60%33.10%33.10%37.80%
Public64.40%66.90%66.90%62.20%

Charges & borrowings

Open charges
₹18.4 Cr
Satisfied charges
₹74.75 Cr
Breakdown by lending institutions
Others₹18.35 Cr
State Bank of India₹0.05 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
02 Mar 2023100711220Others₹18.35 CrOpen
31 Mar 2021100456760State Bank of India₹4.5 LakhOpen
25 Aug 2020100364651Others₹75 LakhSatisfied
06 Feb 2018100186633Others₹30 CrSatisfied
08 Jun 2017100114310Others₹17 CrSatisfied

To see the full charge records of Kerala Ayurveda Limited, buy the company report.

Total charge records: 18 View all charges

Deals & funding

Kerala Ayurveda Limited has 39 deals on record (35 market trades, 4 funding rounds), with disclosed funding of ₹38.89 Cr; the latest was in August 2026.

Total deals
39
Market trades
35
Funding rounds
4
Disclosed funding
₹38.89 Cr

Deals on record (5 of 39)

WhenDealAmountParties
Aug 2026Market trade₹3.85 CrBuyer: Authum Investment & Infrastructure Limited
Seller: Santosh Industries Ltd
Mar 2026Market trade₹1.73 CrBuyer: Zapfin Teknologies Private Limited
Seller: an individual
Sep 2025Market trade₹11.95 CrBuyer: Katra Phytochem (India) Private Limited
Seller: Katra Phytochem (India) Private Limited
Aug 2025Market trade₹10.01 CrSeller: Katra Phytochem (India) Private Limited
Jun 2025Market trade₹6.17 CrBuyer: Kamadgiri Exports Private Limited
Seller: Kamadgiri Exports Private Limited

To see the full deal history of Kerala Ayurveda Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Kerala Ayurveda Limited has 8 MSME Form 1 returns on record between 2020 and 2024, listing 168 overdue payments to 24 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 24)

SupplierAmount dueDue sinceReported on
Five Star Offset Printers
Sree Vinayaga Screens
an individual supplier
an individual supplier
an individual supplier

To see the full MSME payment records of Kerala Ayurveda Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Group structure & subsidiaries

Kerala Ayurveda has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.

1
Subsidiary companies
Key subsidiaries
Company NameCINShares held
Ayurvedagram Heritage Wellness Centre Private LimitedU74140KA2003PTC031511

To see the full group structure of Kerala Ayurveda Limited, buy the company report.

Employees & EPFO

Kerala Ayurveda Limited has a workforce of 592 employees on its EPFO records as of May 2026, across 2 active EPFO establishments.

Employee count
592
Active EPFO establishments
2
Employee growth
22.3%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-27592
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Kerala Ayurveda Limited, buy the company report.

GST

Kerala Ayurveda has 15 GST registrations: 11 active and 4 cancelled or inactive. The first 4 active GSTINs are listed below.

Total GSTINs
15
Active
11
Cancelled / inactive
4
GSTINStateStatusRegistered on
32AABCK4228Q2ZCKeralaActive01 Jul 2017
07AABCK4228Q1Z6DelhiActive01 Jul 2017
29AABCK4228Q1Z0KarnatakaActive01 Jul 2017
33AABCK4228Q1ZBTamil NaduActive01 Jul 2017

To see the full GST registrations and return filing status of Kerala Ayurveda Limited, buy the company report.

Recent activity

Kerala Ayurveda Limited has 50 board changes on record since 1992: 30 appointments and 20 cessations. The latest: Anand Subramanian ceased to be Director on 22 Aug 2025.

Filing
Kerala Ayurveda Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Ernakulam.
AGM
Kerala Ayurveda Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records.
Ceased
Anand Subramanian ceased to be Director.
Appointed
Saif Khan was appointed as Director.
Appointed
Utkarsh Singh was appointed as Director.
Appointed
Kodikannath Jayarajan was appointed as Director.
Appointed
Kshiti Ranjan Das was appointed as Director.
Appointed
Samir Dhawan was appointed as Director.
Ceased
Harish Kuttan Menon ceased to be Director.
Ceased
Gokul Patnaik ceased to be Director.
Ceased
Subramaniam Krishnamurthy ceased to be Director.
Charges
A charge registered on 25 Aug 2020 via Charge ID 100364651 with Others was fully satisfied on 21 Aug 2023.

83 earlier events are in the company report.

News

Frequently asked questions

Kerala Ayurveda is an active public limited company based in Aluva, Kerala, India. The company works in ayurvedic products and services, within the healthcare industry. It was incorporated on 06 July 1992 (34+ years old) and is registered under CIN L24233KL1992PLC006592. Listed on BSE: 530163.

Kerala Ayurveda reported revenue of ₹131.15 Cr for FY 2025-26 (up 4.4% YoY) based on consolidated financials.

Kerala Ayurveda has 8 current directors:

The latest financial statements of Kerala Ayurveda on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 26 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Kerala Ayurveda is 32AABCK4228Q2ZC, registered in Kerala. The company has 15 GST registrations in all, of which 11 are active and 4 are cancelled or inactive. Other active GSTINs include 07AABCK4228Q1Z6 (Delhi), 29AABCK4228Q1Z0 (Karnataka), 33AABCK4228Q1ZB (Tamil Nadu).

The CIN (Corporate Identification Number) of Kerala Ayurveda is L24233KL1992PLC006592. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Yes. Kerala Ayurveda is a listed company as per MCA records. Its shares are listed on BSE (code: 530163).

Kerala Ayurveda has 71 court cases on record: 41 filed by the company and 30 filed against it. 16 are pending. Most are in the district courts.

Kerala Ayurveda was incorporated on 06 July 1992, making it 34+ years old. It is registered with the Registrar of Companies, Ernakulam.

Kerala Ayurveda has 39 deals on record (35 market trades, 4 funding rounds), with disclosed funding of ₹38.89 Cr; the latest was in August 2026.

The peers of Kerala Ayurveda by revenue are Star Hi Herbs Private Limited, Anantshriveda Private Limited, Cultivator Natural Products Private Limited, Maharishi Ayurveda Products Private Limited, all in the Healthcare industry (Ayurvedic Products and Services), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Anand Subramanian ceased to be Director on 22 Aug 2025. Saif Khan was appointed as Director on 30 Jun 2025. Utkarsh Singh was appointed as Director on 19 Mar 2025. Kerala Ayurveda has 50 board changes on record in total.